Cargando…

Refractory Hydroa Vacciniforme-like Lymphoma: Biological Insights from Morphoproteomic Analysis

T-cell/natural killer cell lymphoproliferative disorders are rare, associated with poor overall survival, and have limited treatment options. We report a case of a patient who developed hydroa vacciniforme-like lymphoma (HVLL, an EBV-peripheral T-cell lymphoma), refractory to multiple lines of syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goswamy, Rohit, Ajufo, Helen, Maiti, Abhishek, Brown, Robert, Juneja, Harinder, Apostolidou, Effrosyni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831872/ https://www.ncbi.nlm.nih.gov/pubmed/36694700

Ejemplares similares

Extensive hydroa vacciniforme
por: de Almeida, Hiram Larangeira, et al.
Publicado: (2013)

Hydroa Vacciniforme-Like Cutaneous T-cell Lymphoma
por: Shi, Jian-Qiang, et al.
Publicado: (2014)

Hydroa vacciniforme-like lymphoproliferative disorder in Korea
por: Han, Byeol, et al.
Publicado: (2020)

Hydroa Vacciniforme-Like Lymphoma with Systemic Symptoms: Two Case Reports
por: Wang, Litao, et al.
Publicado: (2019)

Hydroa vacciniforme as a differential diagnosis of atopic dermatitis
por: Brom, Lucas, et al.
Publicado: (2015)

Hydroa vacciniforme-like lymphoma of an adult: a case report with review of the literature
por: Wang, Mi, et al.
Publicado: (2013)

Adult-onset Hydroa Vacciniforme: A Rare Occurrence or a Lymphoma Premonition?
por: Sangwan, Ankita, et al.
Publicado: (2017)

Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein–Barr Virus Infection
por: Chen, Chien-Chin, et al.
Publicado: (2020)

Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: A case report
por: Li, Jingyi, et al.
Publicado: (2018)

Adult-onset hydroa vacciniforme-like lymphoma in a long-term resident of the United States
por: Yu, Kenneth K., et al.
Publicado: (2018)

The face of CD4(+) Hydroa Vacciniforme-Like Lymphoproliferative Diseases: The Shadow of Systemic T-Cell Lymphoma
por: Kim, Young Jae, et al.
Publicado: (2019)

Marked Increase of Circulating Double-Negative γδ T Cells in a Patient With Hydroa Vacciniforme-Like Lymphoma
por: Shin, Sang-Yong, et al.
Publicado: (2016)

Hydroa Vacciniforme-Like Lymphoproliferative Disorder in an Adult Patient With Chronic Lymphocytic Leukemia
por: Chee, Ashlyn, et al.
Publicado: (2020)

A Case of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Presenting As Orogenital Ulcerations
por: Li, Yingyi, et al.
Publicado: (2022)

Hydroa Vacciniforme-Like Eruption Associated with Epstein-Barr Virus Infection in an Older Adult
por: Jung, Soo-Eun, et al.
Publicado: (2015)

Atypical hydroa vacciniforme mimicking dermatomyositis: A case report in a Lebanese girl
por: Hijazi, Maya, et al.
Publicado: (2015)

Hydroa vacciniforme‐like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China
por: Wang, Xinhua, et al.
Publicado: (2021)

Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease()()
por: Ordoñez-Parra, Juliana, et al.
Publicado: (2021)

Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases
por: Guo, Na, et al.
Publicado: (2019)

Clinical and Pathological Features of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Along with Risk Factors Indicating Poor Prognosis
por: Chang, Li, et al.
Publicado: (2023)

Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA
por: Oh, Se Jin, et al.
Publicado: (2021)

Hydroa Vacciniforme-like Lymphoproliferative Disorder Treated with Intravenous Immunoglobulin: Long-term Remission Without Haematopoietic Stem Cell Transplantation or Chemotherapy
por: RUAN, YePing, et al.
Publicado: (2020)

Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review
por: Wang, Xiankun, et al.
Publicado: (2021)

Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis
por: Brown, Robert E., et al.
Publicado: (2017)

Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection
por: Grześk, Elżbieta, et al.
Publicado: (2022)

Chronic active Epstein–Barr virus and hydroa vacciniforme‐like lymphoproliferative disorder in a pediatric patient complicated by fatal ruptured cerebral artery aneurysm
por: Yi, Troy, et al.
Publicado: (2023)

Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells
por: Hirai, Yoji, et al.
Publicado: (2023)

Hydroa, or Fever Blisters
por: Pease, G. M.
Publicado: (1890)

A Case of Hydroa Gravidarum
por: Gupta, A.
Publicado: (1924)

Report of Two Cases of Hydroa
por: Bennett, Edwin R.
Publicado: (1883)

Morphoproteomics and biomedical analytics coincide with clinical outcomes in supporting a constant but variable role for the mTOR pathway in the biology of congenital hyperinsulinism of infancy
por: Brown, Robert E., et al.
Publicado: (2017)

Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options
por: Brown, Robert E., et al.
Publicado: (2016)

Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures
por: Subbiah, Vivek, et al.
Publicado: (2011)

Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options
por: Brown, Robert E., et al.
Publicado: (2017)

Morphoproteomic Profiling of the Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Desmoplastic Small Round Cell Tumor (EWS/WT1), Ewing’s Sarcoma (EWS/FLI1) and Wilms’ Tumor(WT1)
por: Subbiah, Vivek, et al.
Publicado: (2013)

Pleural Transport Physiology: Insights from Biological Marker Measurements in Transudates
por: Apostolidou, Eleni, et al.
Publicado: (2011)

Morphoproteomics and biomedical analytics confirm the mTORC2/Akt pathway as a resistance signature and activated ERK and STAT3 as concomitant prosurvival/antiapoptotic pathways in metastatic renal cell carcinoma (RCC) progressing on rapalogs: Pathogenesis and therapeutic options
por: Brown, Robert E., et al.
Publicado: (2016)

Biological insights into the role of TET2 in T cell lymphomas
por: Carty, Shannon A.
Publicado: (2023)

JAK inhibitors for refractory lymphoma
por: Kimura, Hiroshi
Publicado: (2018)

Relapsed/Refractory Hodgkin Lymphoma
por: Sheikh, Semira, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lfsfquflv34na0f36mv5rj4v85